Hereditary α-tryptasemia is Associated With Anaphylaxis to Antibiotics and Monoclonal Antibodies
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
40239920
DOI
10.1016/j.jaip.2025.04.013
PII: S2213-2198(25)00369-1
Knihovny.cz E-zdroje
- Klíčová slova
- Anaphylaxis, Antibiotics, Drug allergy, Hereditary α-tryptasemia, Monoclonal antibodies, α-Tryptase,
- MeSH
- anafylaxe * genetika epidemiologie MeSH
- antibakteriální látky * škodlivé účinky MeSH
- dospělí MeSH
- genotyp MeSH
- léková alergie * genetika epidemiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- monoklonální protilátky * škodlivé účinky imunologie MeSH
- prevalence MeSH
- prospektivní studie MeSH
- senioři MeSH
- syndrom aktivace žírných buněk MeSH
- tryptasy * genetika krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Slovinsko epidemiologie MeSH
- Názvy látek
- antibakteriální látky * MeSH
- monoklonální protilátky * MeSH
- tryptasy * MeSH
BACKGROUND: Hereditary α-tryptasemia, a genetic trait caused by increased α-tryptase copy number, is associated with idiopathic and venom anaphylaxis. OBJECTIVE: We aimed to determine the impact of tryptase genotypes on drug-induced anaphylaxis. METHODS: A prospective discovery cohort of 99 patients from a referral center in Slovenia with acute anaphylaxis to drugs underwent tryptase genotyping by droplet digital PCR. For validation, we included a cohort of 26 patients from the Czech Republic. Associated inciting agents and the severity of the reactions were subsequently examined. RESULTS: Hereditary α-tryptasemia was associated with drug-induced anaphylaxis with a prevalence of 13% (n = 13 of 99) in the discovery cohort and 15% in the validation cohort (n = 4 of 26). Hereditary α-tryptasemia was identified in every individual with elevated basal serum tryptase levels (11.6-21.9 ng/mL; n = 14) within both cohorts of patients. Hereditary α-tryptasemia was more prevalent in individuals with antibiotic- or mAb-induced anaphylaxis in both the discovery and validation cohorts (n = 13 of 51; 26%) compared to those with anaphylaxis resulting from neuromuscular blocking agents, nonsteroidal anti-inflammatory drugs, contrast, chlorhexidine, or other drugs (n = 5 of 74; 7%; P = .02; odds ratio = 4.1; 95% CI, 1.3-11.1). Overall, we found fewer individuals with no ⍺-tryptase than in the general population, and there was a trend for subjects with more ⍺-tryptase copies to have more severe reactions. Thus, among subjects with three ⍺-tryptase copies, the prevalence of severe anaphylaxis was 73%, compared with 59% with one to two ⍺-tryptase copies and 58% for subjects without ⍺-tryptase. CONCLUSIONS: Risk for anaphylaxis to antibiotics and biologics is associated with inherited differences in α-tryptase-encoding copies at Tryptase α/β1.
GENNET s r o Department of Allergy and Clinical Immunology Prague Czech Republic
GNTlabs by GENNET Centre of Medical Genetics and Reproductive Medicine GENNET Prague Czech Republic
Citace poskytuje Crossref.org